suramin has been researched along with Bacterial Infections in 2 studies
Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.
Bacterial Infections: Infections by bacteria, general or unspecified.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sanner, BM | 1 |
Doberauer, C | 1 |
Tepel, M | 1 |
Zidek, W | 1 |
Toshkov, A | 1 |
Neychev, H | 1 |
Dimov, V | 1 |
2 other studies available for suramin and Bacterial Infections
Article | Year |
---|---|
Fulminant disease simulating bacterial sepsis with disseminated intravascular coagulation after a trip to East Africa.
Topics: Africa, Eastern; Animals; Bacterial Infections; Diagnosis, Differential; Disseminated Intravascular | 2000 |
Suramin increases the nonspecific antibacterial resistance through macrophage activation.
Topics: Animals; Bacterial Infections; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Immun | 1986 |